AzTrials
AzTrials

Horticultural TherapyHortitherapyNCT05381259

Effectiveness of Hortitherapy on the Immediate Well-being of Elderly People With Alzheimer's Disease or Related in Day Care

A study testing hortitherapy in people living with Alzheimer's taking place in three different day care in people with Horticultural Therapy, run by Centre Médical Porte Verte at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Currently, there are an estimated 47 million people with dementia worldwide, with approximately 10 million new cases diagnosed each year. This figure is expected to triple to 130 million in 2050. In France, the number of dementia cases is estimated at 754,000 and could reach 1,813,000 in 2050. Read more about this study

Who is it for?
Ages 60 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Horticultural Therapy
What is being tested?
hortitherapy in people living with Alzheimer's taking place in three different day care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteFrance
Study dates
4 May 2022to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patient having signed an informed and written consent,
  • Patient aged over 60,
  • Patient with Alzheimer's or related disease,
  • Patient benefiting from day care,
  • Patient under guardianship or curatorship.

Who cannot join

  • Patient in period of adaptation in day care,
  • Patient in temporary care at day care,
  • Patient having participated in less than 4 horticultural workshops during the cycle,
  • Patient with severe asthma and/or an allergy that does not allow workshops to be carried out,
  • Patient with major behavioral problems that make it impossible to carry out the workshops.

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • CentreMédicalPorteVerte

    Versailles, 78000

    Adèle de Malherbe, Dr, 0033139637444, ademalherbe@hopitalporteverte.com

    Dr

    Recruiting

Other trials in France

About this study

Currently, there are an estimated 47 million people with dementia worldwide, with approximately 10 million new cases diagnosed each year. This figure is expected to triple to 130 million in 2050.

In France, the number of dementia cases is estimated at 754,000 and could reach 1,813,000 in 2050.

Read more

In a recent literature review, researchers highlighted the many benefits of horticultural therapy and garden environments for people with Alzheimer's or cognitive disorders. They include: alleviating pain, improving attention, decreasing stress, relieving agitation, decreasing the use of medications, such as antipsychotics, as well as reducing falls.

Gardening offers a non-pharmacological approach to achieving these goals and could improve the quality of life for people with Alzheimer's disease or another dementia. As part of a care solution, support services that include social activities, such as gardening, reduce the need for more intrusive and expensive care solutions.

The objective of this research is to evaluate the impact of horticultural

Read the detailed description

This research is an interventional study involving the human person of category 2 involving only minimal risks and constraints, it is prospective, multicenter and non-randomized.

The study will take place with users of the Lépine Versailles day care centre, the La Porte Verte hospital and the Les Magnolias Geriatric Center, living with cognitive disorders. For the purposes of this study, understanding the instructions is required.

The people welcomed will participate in their usual day supervised by the day reception team.

Part of the group having agreed to participate in the study will carry out the horticultural workshop while the other group will benefit from the workshop usually offered. The study will be done with 52 users with the participation of a supervisor to animate the workshops of the different groups.

Each site will have a workshop that will take place in the morning from 11 a.m. to 12 p.m. and one in the afternoon from 2:30 p.m. to 3:30 p.m. This will make it possible to compare the well-being of users according to the time of the workshop.

Being tested
hortitherapy in people living with Alzheimer's taking place in three different day care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • hortitherapy in people living with Alzheimer's taking place in three different day careBehavioural

    6 users benefiting from the horticultural workshop and 6 others from a usual workshop (control group) This control group will benefit from its usual workshop while the other group will participate in the horticultural workshop.

    If it is impossible to carry out the workshops outdoors (rain or high heat), the day reception centers will provide a room to allow the workshops to be carried out. They will be adapted in terms of activities and materials.

Study groups in NCT05381259
Study groupRoleWhat they receive
hortitherapy intervention versus controlOtherHorticultural therapy refers to physical and psychic therapy by nature by focusing on the action of gardening on the body, intellect, psych and mind. Horticultural in the form of therapeutic gardening serves as a support to help and treat various pathologies in the brain. It is a form of curative treatment exploiting the planting and maintenance of garden. The term is a contraction of " horticultural " and " therapy".
Receives: Behavioral: hortitherapy in people living with Alzheimer's taking place in three different day care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EVIBE : An instant assessment scale of perceived well-being in people with major cognitive problems.

    The score of the EVIBE scale is a numerical score between 0 and 5, it will be compared between the two groups, the patients will be integrated randomly in order to take into account the correlation between the data due to the repeated nature of the measurements.

    The regression application conditions will be checked graphically on the residuals. If they are not respected, alternative strategies will be studied (log transformation, bootstrap test)

    Measured: Eight months

Secondary outcomes (2)
  1. Tinetti test : Assessment of walking and balance (Tinetti 1986).

    The Tinetti test is an effective and reproducible tool for the assessment of the risk of falling, its administration time is approximately 5 to 10 minutes and evaluates static and dynamic balance.

    Measured: Eight months

  2. HAD Scale : Hospital Anxiety and Depression

    The advantage of this scale is to quickly and simultaneously assess depressive and anxious dimensions using a short questionnaire. The scale is collected on inclusion and after the 8 weeks of treatment.

    Measured: Eight months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2022
  2. Study start4 May 2022
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion31 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Part of the group having agreed to participate in the study will carry out the horticultural workshop while the other group will benefit from the workshop usually offered.
Masking
None (open label)
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05381259
Sponsor's protocol ID
2022-A00357-36
Acronym
Hortitherapy
Status last verified
May 2022
First submitted
3 May 2022
Last updated
10 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing hortitherapy in people living with Alzheimer's taking place in three different day care in people with Horticultural Therapy, run by Centre Médical Porte Verte at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marine ZAIBAT (+33039637491, mzaibat@hopitalporteverte.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EVIBE : An instant assessment scale of perceived well-being in people with major cognitive problems. (time frame: Eight months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in